. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study. Clin Chem Lab Med. 2015 Feb 1;53(3):453-60. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
MCI-AD
(31)
442.4 ± 114.6
pg/mL
ELISA;
Other/Not Specified;
Innogenetics
McKhann et al., 1984
Aβ42
(CSF)
MCI-Stable
(23)
869.9 ± 335.4
pg/mL
ELISA;
Other/Not Specified;
Innogenetics
Petersen et al., 1999
tau-p181
(CSF)
MCI-AD
(31)
101.4 ± 61.5
pg/mL
ELISA;
Other/Not Specified;
Innogenetics
McKhann et al., 1984
tau-p181
(CSF)
MCI-Stable
(23)
59.6 ± 24.3
pg/mL
ELISA;
Other/Not Specified;
Innogenetics
Petersen et al., 1999
tau-total
(CSF)
MCI-AD
(31)
466.5 ± 292.4
pg/mL
ELISA;
Other/Not Specified;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
MCI-Stable
(23)
361.6 ± 357.3
pg/mL
ELISA;
Other/Not Specified;
Innogenetics
Petersen et al., 1999

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.